Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Mutations: Results From the IFCT-1703 R2D2 Trial.

Autor: Mazieres, Julien, Lafitte, Claire, Ricordel, Charles, Greillier, Laurent, Negre, Elodie, Zalcman, Gérard, Domblides, Charlotte, Madelaine, Jeannick, Bennouna, Jaafar, Mascaux, Céline, Moro-Sibilot, Denis, Pinquie, François, Cortot, Alexis B, Otto, Josiane, Cadranel, Jacques, Langlais, Alexandra, Morin, Franck, Westeel, Virginie, Besse, Benjamin
Zdroj: Journal of Clinical Oncology; 3/1/2022, Vol. 40 Issue 7, p719-728, 10p
Databáze: Supplemental Index